Search results
Showing 4516 to 4530 of 8930 results
Xpert Carba-R to identify people carrying carbapenemase-producing organisms (MIB52)
NICE has developed a medtech innovation briefing (MIB) on the Xpert Carba-R to identify people carrying carbapenemase-producing organisms
NICE has developed a medtech innovation briefing (MIB) on the Aquilion PRIME CT scanner for imaging coronary artery disease in adults in whom imaging is difficult .
NICE has developed a medtech innovation briefing (MIB) on Proov Confirm for ovulation confirmation .
NICE has developed a medtech innovation briefing (MIB) on MiraQ cardiac TTFM with high-frequency probe for assessing graft flow during coronary artery bypass graft surgery .
PROPATEN heparin-bonded vascular graft for peripheral arterial disease (MIB42)
NICE has developed a medtech innovation briefing (MIB) on the PROPATEN heparin-bonded vascular graft for peripheral arterial disease
NICE has developed a medtech innovation briefing (MIB) on the ATEC breast biopsy system
NICE has developed a Medtech Innovation Briefing (MIB) on the AccuVein AV400 for vein visualisation
NICE has developed a medtech innovation briefing (MIB) on the Quantitative Timed Up and Go (QTUG)
Alair bronchial thermoplasty system for adults with severe difficult to control asthma (MIB71)
NICE has developed a medtech innovation briefing (MIB) on the Alair bronchial thermoplasty system for adults with severe, difficult to control asthma
NICE has developed a medtech innovation briefing (MIB) on the S-Cath System for suprapubic catheterisations
Active B12 assay for diagnosing vitamin B12 deficiency (MIB40)
NICE has developed a medtech innovation briefing (MIB) on the Active-B12 assay for diagnosing vitamin B12 deficiency
Recommendation ID NG156/2 Question What is the effectiveness and cost effectiveness of complex endovascular aneurysm repair (EVAR) versus
Recommendation ID NG48/1 Question Access to dental services in England for adults in care homes:- What effect does improving and maintaining
Recommendation ID NG57/5 Question Access to medicines:- Does the use of directly observed supply of named high-risk medicines (that is
What are the risk factors for acne vulgaris-related scarring?
Recommendation ID NG198/6 Question What are the risk factors for acne vulgaris-related scarring? Any explanatory notes(if applicable)